Goldsmith: “Extreme Secrecy… Led to a Lot of Mistakes”
In October, the Senate Judiciary Committee held a riveting hearing with Jack Goldsmith, the former head of the Justice Department Office of Legal Counsel. The record of that hearing has just been published.
As was widely reported at the time, Mr. Goldsmith challenged the legality of certain aspects of the President’s warrantless surveillance program and raised questions about other policies and procedures in the “war on terrorism.”
“There’s no doubt that the extreme secrecy [surrounding the Terrorist Surveillance Program] — not getting feedback from experts, and not showing it to experts, and not getting a variety of views, even inside the executive branch — led to a lot of mistakes,” he said.
The PDF version of the hearing record includes Mr. Goldsmith’s answers to questions for the record from the Senate Committee members (pp. 38-49). In most cases, he deflected the Senators’ pointed questions. But several of the exchanges are interesting nevertheless.
Asked about the Administration’s refusal to disclose to Congress the legal memoranda justifying its interrogation program, Mr. Goldsmith stated:
“I believe it is the President’s prerogative not to disclose these opinions. And I believe it is the Congress’s prerogative to use political pressure to try to force the Executive to disclose the opinions.”
See “Preserving the Rule of Law in the Fight Against Terrorism,” hearing before the Senate Judiciary Committee, October 2, 2007.
The transition to a clean energy future and diversified sources of energy requires a fundamental shift in how we produce and consume energy across all sectors of the U.S. economy.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.